RadNet Inc. (NASDAQ:RDNT) insider John V. Crues sold 19,684 shares of the business’s stock in a transaction that occurred on Tuesday, December 19th. The shares were sold at an average price of $10.01, for a total value of $197,036.84. Following the completion of the sale, the insider now owns 544,097 shares of the company’s stock, valued at approximately $5,446,410.97. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
RadNet Inc. (NASDAQ:RDNT) traded down $0.35 during trading hours on Friday, reaching $10.30. 121,584 shares of the company’s stock traded hands, compared to its average volume of 192,619. The company has a debt-to-equity ratio of 7.88, a quick ratio of 1.29 and a current ratio of 1.29. RadNet Inc. has a one year low of $5.25 and a one year high of $11.90. The stock has a market capitalization of $507.20, a price-to-earnings ratio of 44.78, a price-to-earnings-growth ratio of 2.32 and a beta of 0.83.
RadNet (NASDAQ:RDNT) last posted its earnings results on Thursday, November 9th. The medical research company reported $0.12 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.12. RadNet had a net margin of 1.21% and a return on equity of 23.73%. The business had revenue of $227.60 million for the quarter, compared to analyst estimates of $232.84 million. During the same period in the prior year, the company posted $0.11 EPS. The company’s revenue for the quarter was up 1.3% on a year-over-year basis. research analysts predict that RadNet Inc. will post 0.35 EPS for the current year.
A number of equities analysts have recently issued reports on RDNT shares. Zacks Investment Research downgraded RadNet from a “hold” rating to a “sell” rating in a research report on Wednesday, October 4th. TheStreet lowered shares of RadNet from a “b-” rating to a “c” rating in a report on Friday, October 27th. Finally, BidaskClub raised shares of RadNet from a “sell” rating to a “hold” rating in a report on Saturday, January 6th.
Hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its holdings in shares of RadNet by 2.5% during the 1st quarter. Vanguard Group Inc. now owns 1,233,623 shares of the medical research company’s stock worth $7,278,000 after buying an additional 30,054 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of RadNet by 6.6% during the 1st quarter. Geode Capital Management LLC now owns 274,192 shares of the medical research company’s stock worth $1,617,000 after purchasing an additional 16,924 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of RadNet by 3.2% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,419,656 shares of the medical research company’s stock worth $8,376,000 after purchasing an additional 43,960 shares during the period. Bank of America Corp DE boosted its position in shares of RadNet by 5.9% during the 1st quarter. Bank of America Corp DE now owns 26,580 shares of the medical research company’s stock worth $157,000 after purchasing an additional 1,477 shares during the period. Finally, Schwab Charles Investment Management Inc. boosted its position in shares of RadNet by 18.4% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 163,032 shares of the medical research company’s stock worth $1,264,000 after purchasing an additional 25,300 shares during the period. Institutional investors own 53.16% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “RadNet Inc. (RDNT) Insider Sells $197,036.84 in Stock” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US and international copyright and trademark laws. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2018/01/13/radnet-inc-rdnt-insider-john-v-crues-sells-19684-shares.html.
RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.
Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.